$MNKD Recent News S&P 500 posts strongest 2nd quarter

New Post Public Reply Private Reply Replies (0) Message Board

Jul 21, 2014 at 11:12 AM

$MNKD Recent News

S&P 500 posts strongest 2nd quarter since 2009: Stock market live blog recap 3:33 p.m. June 30, 2014 - blogs.marketwatch.com
MannKind, GoPro rise; Yahoo gains on upgrade 12:02 p.m. June 30, 2014 - Sue Chang
MannKind shares up 23.1% in premarket trade 7:19 a.m. June 30, 2014 - Ciara Linnane
Six more bull months ahead, and GoPro keeps on going 6:28 a.m. June 30, 2014 - Sara Sjolin
MannKind wins approval for its inhaled insulin — and its stock drops? 4:30 p.m. June 27, 2014 - Russ Britt
DuPont falls on outlook; Michaels debuts 4:08 p.m. June 27, 2014 - Sue Chang
3 overlooked stocks loved by top-ranked advisers 3:09 p.m. April 25, 2014 - Mark Hulbert
Tesla, Facebook seesaw; Questcor surges on deal 3:54 p.m. April 7, 2014 - Sue Chang
MannKind drops after FDA says its review on drug will last until July 1:46 p.m. April 7, 2014 - Russ Britt
Stock futures drop as earnings season looms 9:20 a.m. April 7, 2014 - Sara Sjolin
MannKind drops 12% after FDA review extension 7:15 a.m. April 7, 2014 - Ben Eisen
MannKind drops 16% after FDA review extension 7:01 a.m. April 7, 2014 - Ben Eisen
U.S. stocks up; S&P 500 hits record 9:15 a.m. April 3, 2014 - Anora Mahmudova
MannKind soars on drug recommendation; Apollo slumps 4:13 p.m. April 2, 2014 - Sue Chang
Myriad shares soar after Medicare reimbursements get a 37% boost 1:44 p.m. April 2, 2014 - Russ Britt
MannKind shares nearly double after FDA panel OKs insulin treatment 10:40 a.m. April 2, 2014 - Russ Britt
Stock futures pare gains after ADP 8:59 a.m. April 2, 2014 - Barbara Kollmeyer
MannKind: FDA committee recommends Afreeza OK 7:14 a.m. April 2, 2014 - MarketWatch.com
MannKind soars 97% after FDA panel nod for Afrezza 7:14 a.m. April 2, 2014 - Barbara Kollmeyer
Apollo shares slip after revenue falls short 6:54 p.m. April 1, 2014 - Wallace Witkowski

5 More Possible Partners For MannKind's Afrezza, Each With A Strong Diabetes Care Franchise 9:53 a.m. Today - Seeking Alpha
Top Swing Trade Ideas for Monday July 21: Cliffs Natural Resources, MannKind, PolyOne 9:19 a.m. Today - TheStreet.com
5 Stocks With Bad Sales Growth — HTS MITT UEC LPCN MNKD 4:15 a.m. Today - InvestorPlace.com
Recent Tsunami of Insider Shares Purchased: A Prelude To Mannkind Partnership or Acquisition 10:22 p.m. July 19, 2014 - GuruFocus.com
Hottest Healthcare Stocks Now – IMGN MNKD CNMD NBIX 2:00 p.m. July 18, 2014 - InvestorPlace.com
Mannkind Corporation: Why Afrezza Would Completely Dominate The Insulin Market 6:22 p.m. July 16, 2014 - GuruFocus.com
Yellen, Icahn Comments Put a Lid on Small-Cap Stocks, May Hurt Larger Market 11:40 a.m. July 16, 2014 - TheStreet.com
Stock Market Today: Social Media, Biotech Suffer as Janet Yellen Shares Concerns on Valuation 4:19 p.m. July 15, 2014 - TheStreet.com
Fed Chair Yellen Says Small Biotech Stocks Over-Valued 1:10 p.m. July 15, 2014 - TheStreet.com
MannKind: Are These Top Big Pharma Companies Potential Partners? 10:15 a.m. July 14, 2014 - Seeking Alpha
Biotech Stock Mailbag: MannKind, Bluebird, Northwest Bio, More '14 Tradable Biotech Events 9:30 a.m. July 14, 2014 - TheStreet.com
5 Stocks With Poor Sales Growth — HTS MITT UEC LPCN MNKD 5:30 a.m. July 14, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – AUXL OPK ARIA MNKD 1:30 p.m. July 11, 2014 - InvestorPlace.com
14 Insanely Important Biotech/Drug Trading Catalysts for the Rest of 2014 11:54 a.m. July 10, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – MNKD LCI NPSP PBH 1:45 p.m. July 9, 2014 - InvestorPlace.com
MannKind Corporation (MNKD): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. July 9, 2014 - Zacks.com
Biggest Movers in Healthcare Stocks Now – GPRO MNKD STJ CVD 9:00 a.m. July 7, 2014 - InvestorPlace.com
5 Stocks With Crummy Sales Growth — HTS MITT UEC LPCN MNKD 4:15 a.m. July 7, 2014 - InvestorPlace.com
Thirteen Analyst Stocks Under $10 With Huge Upside Potential 8:48 a.m. July 5, 2014 - 247WallSt.com
Cramer's Mad Money - 5 Stocks That Pushed The Dow Higher (7/2/14) 6:24 a.m. July 3, 2014 - Seeking Alpha

Critical Alerts For MannKind, CVS Caremark, Express Scripts, Cheniere Energy, and HomeAway Released By InvestorsObserver 9:31 a.m. Today - PR Newswire - PRF
NDA Submission, Results Release Schedules, FDA Grants and Approvals, and Agreements - Analyst Notes on Gilead, Biogen Idec, Amgen, Illumina and MannKind 5:20 a.m. July 4, 2014 - PR Newswire - PRF
MannKind Corp Analyst Report; Afrezza is Approved and Future Developments by BrokerBank Securities, Inc. 11:15 a.m. July 3, 2014 - PR Newswire - PRF
Critical Alerts For MannKind, AOL, Plug Power, Ctrip.com, and 58.com Released By InvestorsObserver 9:31 a.m. July 1, 2014 - PR Newswire - PRF
MannKind Corporation Announces FDA Approval of AFREZZA(R); A Novel, Rapid-Acting Inhaled Insulin for the Treatment of Diabetes 5:07 p.m. June 27, 2014 - GlobeNewswire
Leadership Appointments, Approved Acquisitions, Licensing Agreements, Technical UPdate, and Response to Tender Offer Announcement - Analyst Notes on Actavis, Forest, Vertex, MannKind and Gentiva 5:20 a.m. June 26, 2014 - PR Newswire - PRF
Critical Alerts For Netflix, MannKind, Dish Network, Illumina, and Anheuser-Busch InBev Technology Released By InvestorsObserver 9:31 a.m. June 6, 2014 - PR Newswire - PRF
MannKind to Present at Upcoming Conferences 9:01 a.m. May 27, 2014 - GlobeNewswire
Reveal Insider Trading for Facebook, MannKind, QUALCOMM, American Realty Capital Properties, salesforce.com, and Symantec 8:55 a.m. May 22, 2014 - PR Newswire - PRF
Technical Data on Top Gainers -- Research on MannKind, Intermolecular, FireEye, and Yingli Green Energy Holding 9:10 a.m. May 20, 2014 - PR Newswire - PRF
Earnings Release Results, and Leadership Appointments - Analyst Notes on Halozyme, MannKind, Arrowhead, Idera and BioCryst 7:00 a.m. May 16, 2014 - PR Newswire - PRF
Critical Alerts For Citigroup, Linn Energy, MannKind, Canadian Solar, and Qualcomm Released By InvestorsObserver 9:31 a.m. May 15, 2014 - PR Newswire - PRF
MannKind Corporation Pending FDA Approval Inspires Analyst Report by BrokerBank Securities, Inc. 8:00 a.m. May 14, 2014 - PR Newswire - PRF
MannKind Corporation Reports 2014 First Quarter Financial Results 9:02 a.m. May 12, 2014 - GlobeNewswire
MannKind to Present at Bank of America Merrill Lynch 2014 Health Care Conference 5:01 p.m. May 7, 2014 - GlobeNewswire
MannKind Corporation to Hold 2014 First Quarter Financial Results Conference Call on May 12, 2014 9:02 a.m. May 5, 2014 - GlobeNewswire
Active Stocks Technical Review -- Research on AES Corp., Baidu, Hertz Global Holdings, and MannKind 1:01 p.m. April 30, 2014 - PR Newswire - PRF
Abattis Bioceuticals Corp. Enters Into Share Agreement with Experion 10:01 a.m. April 17, 2014 - ACCESSWIRE
Elite Pharmaceuticals to Receive up to 40 Million from Lincoln Park Capital Fund 10:02 a.m. April 15, 2014 - ACCESSWIRE
Critical Alerts For Walt Disney, Walgreen, BioMarin Pharmaceuticals, Canadian Solar, and MannKind Released By InvestorsObserver 9:31 a.m. April 14, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hollywood Vampires' Limited Art Sparks Las Vegas Buzz

A Collaboration to Captivate Art and Rock Enthusiasts When it comes to mixing rock and roll with fine art, Markus Klinko's exclusive photograph featuring the Hollywood Vampires hits the nail on the head. It’s not just an image; it’s a slice of modern rock history immortalized on paper. This new release, a portrait capturing the raw passion of Alice Cooper, Johnny...

Jacobi's Harness Brings AI from Concept to Reality

The Challenge of Moving AI to Production Diving headfirst into AI in finance? Well, Jacobi's bold move with their new toy, the Investment Management Harness, spotlights a filthy secret: the hurdles between a big idea and execution are seldom technological. We got AI shaving prototyping time down to just days, yet pushing to production? That's a marathon in itself. Boards...

Innovative Trial Targets Drug Resistance in Lung Cancer

The Battle Against Drug Resistance Heats Up Folks, we're in a never-ending fight here against one of the toughest adversaries out there: lung cancer. And lemme tell ya, when drugs show resistance, it's like trying to punch a ghost. But there’s a fresh wind blowing, as Dr. Bobak Parang steps up to the plate with a $620K grant aimed squarely at tackling drug resistance in...

Cavli360 Unites Global IoT Voices in New Magazine

Connecting IoT Insights: A Fresh Spin on Industry Collaboration Alright, stepping away from stocks and straight into tech talk—Cavli Wireless just dropped their shiny new industry mag, Cavli360, aiming to be a voice hub for all things IoT. This ain't just another glossy promo piece; it's a rallying cry to bring together the brains across the nets and fibers shaping our...

Enertech's New Moves Aim to Make Geothermal Mainstream

Breaking Through Financial Barriers in Geothermal Energy Finally, we're seeing some real movement in the geothermal heat pump sector. The longtime hurdles that kept ground-sourced heating and cooling tech at arm's length from the everyday homeowner are starting to tumble, thanks to Enertech Global's latest initiatives. Enertech's Double Deal: A New Lease on Geothermal...

Sony's LYTIA 720 Image Sensor: A Game Changer?

Unpacking Sony's Latest Sensor: LYTIA 720 Tell me, when was the last time a tech drop made you shake your head in awe? Sony just pulled one of those moves with their latest toy, the LYTIA 720. We're talking a 50-effective megapixel CMOS image sensor crafted for mobile warriors, and it packs a punch that should have the competition looking over their shoulder. Dazzling...

OppFi's Q3 2026: Is Their Growth Strategy on Track?

OppFi's Third Quarter Performance Unpacked OppFi's recent third-quarter disclosures should get investors pondering. They've launched a new line of credit product, plugging a gap in their service portfolio, and aimed to widen their customer net. Their targeted share repurchase of $6.7 million in stock isn't small potatoes either, showing a vote of confidence in their own...

Seasonal Hiring Booms as Firms Eye Long-Term Talent

A Strategic Shift in Seasonal Hiring It ain't just about the holiday rush anymore, folks. Companies are waking up to the idea that seasonal gigs are more than a temporary Band-Aid. This year, nearly 2 out of 5 companies are planning to bring more seasonal folks into the fold compared to last year. That means a good dose of them are looking for longer-term value—like...

Montage Partners Maintains its Founder-Friendly Status

A Streak That Speaks Volumes Did you catch the latest from Scottsdale? Montage Partners, that people-first private equity outfit, just notched its sixth straight year on Inc.'s Founder-Friendly Investors list. Not something you snag with a casual handshake or flimsy promises—this accolade is about real, boots-on-the-ground partnership. Apparently, 294 firms made the...

Psoriasis Shines Spotlight on Stigma in 2026 Campaign

Peeling Back the Layers of Stigma On World Psoriasis Day, we're flipping the script from pity parties to real change. IFPA's 'Look Beyond My Skin' campaign is rallying against the stigma choking young folks with psoriasis. You can't deny the massive size of this issue – over 100 million people wrangle with this condition globally. Yet, as many of these warriors are...